DK339289D0 - Farmaceutisk praeparat - Google Patents

Farmaceutisk praeparat

Info

Publication number
DK339289D0
DK339289D0 DK339289A DK339289A DK339289D0 DK 339289 D0 DK339289 D0 DK 339289D0 DK 339289 A DK339289 A DK 339289A DK 339289 A DK339289 A DK 339289A DK 339289 D0 DK339289 D0 DK 339289D0
Authority
DK
Denmark
Prior art keywords
pharmaceutical preparation
ephedrine
human
reducing
weight
Prior art date
Application number
DK339289A
Other languages
English (en)
Inventor
Arne Astrup
Original Assignee
Dak Lab As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dak Lab As filed Critical Dak Lab As
Priority to DK339289A priority Critical patent/DK339289D0/da
Publication of DK339289D0 publication Critical patent/DK339289D0/da
Priority to HU9200051A priority patent/HU220071B/hu
Priority to DE69010336T priority patent/DE69010336T2/de
Priority to UA93004254A priority patent/UA27779C2/uk
Priority to PCT/DK1990/000106 priority patent/WO1991000730A1/en
Priority to SU5010984A priority patent/RU2109511C1/ru
Priority to AT90907185T priority patent/ATE107858T1/de
Priority to JP2507158A priority patent/JP2584899B2/ja
Priority to CA002063598A priority patent/CA2063598C/en
Priority to ES90907185T priority patent/ES2055911T3/es
Priority to KR1019920700029A priority patent/KR0159045B1/ko
Priority to DK90907185.4T priority patent/DK0480934T3/da
Priority to AU56308/90A priority patent/AU638992B2/en
Priority to EP90907185A priority patent/EP0480934B1/en
Priority to FI920026A priority patent/FI920026A0/fi
Priority to NO92920051A priority patent/NO920051L/no
Priority to US07/996,840 priority patent/US5422352A/en
Priority to LVP-93-94A priority patent/LV10192B/en
Priority to LTIP702A priority patent/LT3536B/lt
Priority to HK98100528A priority patent/HK1001821A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/475—Quinolines; Isoquinolines having an indole ring, e.g. yohimbine, reserpine, strychnine, vinblastine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
DK339289A 1989-07-07 1989-07-07 Farmaceutisk praeparat DK339289D0 (da)

Priority Applications (20)

Application Number Priority Date Filing Date Title
DK339289A DK339289D0 (da) 1989-07-07 1989-07-07 Farmaceutisk praeparat
EP90907185A EP0480934B1 (en) 1989-07-07 1990-04-20 A slimming pharmaceutical composition
CA002063598A CA2063598C (en) 1989-07-07 1990-04-20 Slimming pharmaceutical composition
KR1019920700029A KR0159045B1 (ko) 1989-07-07 1990-04-20 체중감량용 제약 조성물
UA93004254A UA27779C2 (uk) 1989-07-07 1990-04-20 Фармацевтична композиція для лікування зайвої ваги або ожиріння, спосіб лікування цією композицією та спосіб поліпшення якості туші свійської тварини
PCT/DK1990/000106 WO1991000730A1 (en) 1989-07-07 1990-04-20 A slimming pharmaceutical composition
SU5010984A RU2109511C1 (ru) 1989-07-07 1990-04-20 Фармацевтическая композиция и способ лечения избыточного веса или ожирения, способ улучшения качества туши домашнего животного
AT90907185T ATE107858T1 (de) 1989-07-07 1990-04-20 Pharmazeutische zusammensetzung zum abnehmen.
JP2507158A JP2584899B2 (ja) 1989-07-07 1990-04-20 体重減量医薬組成物
HU9200051A HU220071B (hu) 1989-07-07 1990-04-20 Fogyasztó hatású, efedrint és koffeint tartalmazó szinergista gyógyszerkészítmény és eljárás előállítására
ES90907185T ES2055911T3 (es) 1989-07-07 1990-04-20 Compuesto farmaceutico adelgazante.
DE69010336T DE69010336T2 (de) 1989-07-07 1990-04-20 Pharmazeutische zusammensetzung zum abnehmen.
DK90907185.4T DK0480934T3 (da) 1989-07-07 1990-04-20 Lægemiddel, der indeholder ephedrin og koffein til behandling af overvægt
AU56308/90A AU638992B2 (en) 1989-07-07 1990-04-20 A slimming pharmaceutical composition
NO92920051A NO920051L (no) 1989-07-07 1992-01-03 Farmasoeytisk sammensetning for slanking
FI920026A FI920026A0 (fi) 1989-07-07 1992-01-03 Farmaceutisk komposition anvaendbar som avmagringsmedicin.
US07/996,840 US5422352A (en) 1989-07-07 1992-12-21 Slimming pharmaceutical composition
LVP-93-94A LV10192B (en) 1989-07-07 1993-02-03 A slimming pharmaceutical composition
LTIP702A LT3536B (en) 1989-07-07 1993-06-23 A slimming pharmaceutical composition
HK98100528A HK1001821A1 (en) 1989-07-07 1998-01-21 A slimming pharmaceutical composition

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DK339289A DK339289D0 (da) 1989-07-07 1989-07-07 Farmaceutisk praeparat

Publications (1)

Publication Number Publication Date
DK339289D0 true DK339289D0 (da) 1989-07-07

Family

ID=8122369

Family Applications (2)

Application Number Title Priority Date Filing Date
DK339289A DK339289D0 (da) 1989-07-07 1989-07-07 Farmaceutisk praeparat
DK90907185.4T DK0480934T3 (da) 1989-07-07 1990-04-20 Lægemiddel, der indeholder ephedrin og koffein til behandling af overvægt

Family Applications After (1)

Application Number Title Priority Date Filing Date
DK90907185.4T DK0480934T3 (da) 1989-07-07 1990-04-20 Lægemiddel, der indeholder ephedrin og koffein til behandling af overvægt

Country Status (19)

Country Link
US (1) US5422352A (da)
EP (1) EP0480934B1 (da)
JP (1) JP2584899B2 (da)
KR (1) KR0159045B1 (da)
AT (1) ATE107858T1 (da)
AU (1) AU638992B2 (da)
CA (1) CA2063598C (da)
DE (1) DE69010336T2 (da)
DK (2) DK339289D0 (da)
ES (1) ES2055911T3 (da)
FI (1) FI920026A0 (da)
HK (1) HK1001821A1 (da)
HU (1) HU220071B (da)
LT (1) LT3536B (da)
LV (1) LV10192B (da)
NO (1) NO920051L (da)
RU (1) RU2109511C1 (da)
UA (1) UA27779C2 (da)
WO (1) WO1991000730A1 (da)

Families Citing this family (54)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5865869A (en) * 1991-08-02 1999-02-02 Ecologel Usa, Inc. Solution for plant root watering
WO1994000432A1 (en) * 1992-06-30 1994-01-06 The United States Of America, Represented By The Secretary, Department Of Health And Human Services Anorectic epinephrine derivatives
CA2147180A1 (en) * 1992-10-15 1994-04-28 Gokhan S. Hotamisligil Treatment of insulin resistance in obesity linked type ii diabetes using antagonists to tnf-.alpha. function
ES2094687B1 (es) * 1994-08-02 1997-12-16 S A L V A T Lab Sa Combinacion farmaceutica contra la obesidad o el sobrepeso.
FR2746644A1 (fr) * 1996-03-18 1997-10-03 Firion Jackie Produit parapharmaceutique moderateur d'appetit
EP0885008B1 (en) * 1996-09-30 2009-12-30 Dennis Jones The regulation of body weight with materials derived from citrus varieties
US6224873B1 (en) 1996-09-30 2001-05-01 Zhishin, Llc Regulation of appetite, body weight and athletic function with materials derived from citrus varieties
AU728889C (en) 1996-12-23 2001-08-02 S.L.A. Pharma Ag Pharmaceutical composition for treating fecal incontinence and anal itch
US5798101A (en) * 1997-01-22 1998-08-25 Hpf, L.L.C. Herbal appetite suppressant and weight loss composition
US6162455A (en) * 1997-01-22 2000-12-19 American Cyanamid Company Method for increasing lean meat, improving the lean meat to fat ratio and improving amino acid utilization in warm-blooded animals
US5985282A (en) * 1997-01-22 1999-11-16 Hpf, L.L.C. Herbal appetite suppressant and weight loss composition
HUP9700654A2 (hu) * 1997-03-26 1999-09-28 Dezső Korbonits Teobromin tartalmú köhögéscsillapító készítmények
US6468519B1 (en) * 1997-09-10 2002-10-22 Rutgers, The State University Of New Jersey Polyanhydrides with biologically active degradation products
US7232830B2 (en) 1998-06-26 2007-06-19 Elaine A Delack Method for treatment of neurodegenerative diseases and effects of aging
NZ509198A (en) * 1998-06-26 2002-11-26 Elaine A Treatment for multiple sclerosis using a histamine H2 agonist in combination with a phosphodiesterase inhibitor
US6340482B1 (en) 2000-05-18 2002-01-22 Zhishin, Llc Methods for inducing weight loss in a human with materials derived from Citrus varieties
US6113949A (en) * 1998-10-27 2000-09-05 Prolab Nutrition, Inc. Weight control product and method of treating hyperlipidemia and increasing vigor with said product
US6475514B1 (en) * 1998-12-03 2002-11-05 Andrew Blitzer Athletic patch
US6576272B1 (en) * 1999-03-05 2003-06-10 Twin Laboratories Incorporated Dietary supplement and method of using same
WO2001005356A2 (en) * 1999-07-20 2001-01-25 Natrol, Inc. Weight control product comprising a synergistic mixture of guggul extract, phosphate salt and metabolic stimulant
EP1250131A2 (en) * 1999-08-23 2002-10-23 The Administrators Of The Tulane University Educational Fund Modulation of the blood-brain barrier transporter for leptin
US6723737B1 (en) * 1999-10-20 2004-04-20 Eliezer Rapaport Methods, pharmaceutical and therapeutic compostions for administering adenosine
US7115297B2 (en) * 2000-02-22 2006-10-03 Suzanne Jaffe Stillman Nutritionally fortified liquid composition with added value delivery systems/elements/additives
US7892586B2 (en) 2001-02-22 2011-02-22 Suzanne Jaffe Stillman Water containing soluble fiber
US8178150B2 (en) 2000-02-22 2012-05-15 Suzanne Jaffe Stillman Water containing soluble fiber
DE10011541A1 (de) * 2000-03-06 2001-09-20 Reimann Hartmut Verwendung einer Kombination aus Ephedrin und Coffein und/oder Theophyllin zur Vitalisierung von Knochenfischen, Wasserzusatz zur Vitalisierung von Knochenfischen
US6316499B1 (en) 2000-05-18 2001-11-13 Zhishin, Llc Methods for increasing the muscle mass of a human with materials derived from citrus varieties
EP1346726A4 (en) * 2000-12-25 2004-09-15 Shiseido Co Ltd FRAGRANCE COMPOSITION STIMULATING THE SYMPATHETIC SYSTEM
US7048941B2 (en) * 2001-03-30 2006-05-23 New World Enterprizes, Inc. Chocolate composition as delivery system for nutrients and medications
US7041305B2 (en) * 2001-09-07 2006-05-09 Western Holdings, Llc Stable water in oil aminophylline emulsions
GB0130763D0 (en) 2001-12-21 2002-02-06 Norgine Res Ltd Treatment methods
AU2003224507A1 (en) * 2002-04-19 2003-11-03 N.V. Nutricia Multiphasic diet
US8142810B2 (en) * 2002-05-30 2012-03-27 The Procter & Gamble Company Dietary method for modulating glucose metabolism and associated conditions and increasing longevity
US20040077530A1 (en) * 2002-10-18 2004-04-22 Robert Portman Composition for reducing caloric intake
US20040224031A1 (en) * 2003-05-06 2004-11-11 Antonio Zorzano Olarte Combination of amines and vanadium (IV)/(V) compounds for the treatment and/or prevention of diabetes mellitus
US20050130933A1 (en) * 2003-10-17 2005-06-16 Ira Jacobs Weight-loss supplement
CA2545559A1 (en) * 2003-11-20 2005-06-09 Alteragon Pty Ltd. Method of decreasing fat deposits and body weight in mammals and birds
CA2455248A1 (en) * 2004-01-29 2005-07-29 Alexander Zolotoy Oral administration of r-albuterol against obesity
US7524064B2 (en) * 2004-03-09 2009-04-28 Research Foundation Of The State University Of New York Apparatus and method for assessing retinal damage
US20060074057A1 (en) * 2004-10-04 2006-04-06 Eric Marchewitz Use of chenodeoxycholic acid for reducing adipose tissue
US20060134230A1 (en) * 2004-12-17 2006-06-22 Sal Abraham Weight loss composition and formulation
US20060204599A1 (en) * 2005-03-14 2006-09-14 Wheat Jared R Dietary supplement and method of using same
US20090214682A1 (en) * 2008-02-22 2009-08-27 Heuer Marvin A Composition and methods for weight loss in a subject
US9044606B2 (en) 2010-01-22 2015-06-02 Ethicon Endo-Surgery, Inc. Methods and devices for activating brown adipose tissue using electrical energy
US9610429B2 (en) * 2010-12-29 2017-04-04 Ethicon Endo-Surgery, Inc. Methods and devices for activating brown adipose tissue with targeted substance delivery
US9271982B2 (en) 2012-10-08 2016-03-01 Rivalea (Australia) Pty Ltd. Animal feed supplement comprising ractopamine and caffeine
US9877434B2 (en) 2013-05-30 2018-01-30 Ecologel Solutions, Llc Granular compositions and methods for drought mitigation
WO2015143483A1 (en) * 2014-03-26 2015-10-01 Rivalea (Australia) Pty Ltd Method for improving feed efficiency in ruminants
US10080884B2 (en) 2014-12-29 2018-09-25 Ethicon Llc Methods and devices for activating brown adipose tissue using electrical energy
US10092738B2 (en) 2014-12-29 2018-10-09 Ethicon Llc Methods and devices for inhibiting nerves when activating brown adipose tissue
US11547125B2 (en) 2015-02-13 2023-01-10 Mars, Incorporated Pet food feeding system
US20180055848A1 (en) * 2015-04-14 2018-03-01 Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Combination of Albuterol and Caffeine as Synergistic Treatment for Obesity or Sarcopenia
GB201522296D0 (en) 2015-12-17 2016-02-03 Mars Inc Food product to reduce body fat
JP2022532657A (ja) * 2019-05-16 2022-07-15 ネクサス ファーマシューティカルズ， インコーポレイテッド エフェドリンまたはエフェドリン塩を含む組成物ならびにその組成物を作製する方法および使用する方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2390164A1 (fr) * 1977-05-13 1978-12-08 Blanie Paul Association a action anti-asthmatique
NL7710582A (nl) * 1977-06-03 1978-12-05 Pharmaceutical Export Promotio Werkwijze ter bereiding van een vermagerings- preparaat.
US4364922A (en) * 1980-10-14 1982-12-21 University Of Virginia Alumni Patents Foundation Adenosine antagonists in the treatment and diagnosis of A-V node conduction disturbances
US4525359A (en) * 1982-12-10 1985-06-25 Greenway Frank L Iii Treatment for selective weight control
US5011843A (en) * 1988-05-31 1991-04-30 Iolab Corporation Treatment of glaucoma using phosphodiesterase inhibitors

Also Published As

Publication number Publication date
DE69010336T2 (de) 1994-11-03
EP0480934A1 (en) 1992-04-22
LV10192A (lv) 1994-10-20
US5422352A (en) 1995-06-06
KR0159045B1 (ko) 1998-12-01
NO920051L (no) 1992-01-31
JP2584899B2 (ja) 1997-02-26
RU2109511C1 (ru) 1998-04-27
HK1001821A1 (en) 1998-07-10
WO1991000730A1 (en) 1991-01-24
DK0480934T3 (da) 1994-11-07
CA2063598A1 (en) 1991-01-08
HU220071B (hu) 2001-10-28
EP0480934B1 (en) 1994-06-29
DE69010336D1 (de) 1994-08-04
AU638992B2 (en) 1993-07-15
LV10192B (en) 1995-06-20
FI920026A0 (fi) 1992-01-03
JPH04507091A (ja) 1992-12-10
UA27779C2 (uk) 2000-10-16
HU9200051D0 (en) 1992-06-29
HUT62798A (en) 1993-06-28
ES2055911T3 (es) 1994-09-01
AU5630890A (en) 1991-02-06
LTIP702A (en) 1995-01-31
NO920051D0 (no) 1992-01-03
CA2063598C (en) 1997-12-09
ATE107858T1 (de) 1994-07-15
LT3536B (en) 1995-11-27

Similar Documents

Publication Publication Date Title
DK339289D0 (da) Farmaceutisk praeparat
YU47543B (sh) Postupak za dobijanje farmaceutskog preparata za stimulaciju granulocita
ES2162615T3 (es) Metodo para tratar o prevenir diabetes de tipo 1 mediante la administracion oral de insulina.
DE68910159D1 (de) Dosierform für Verabreichung in der Humanmedizin.
PT977564E (pt) Forscolina para promocao da massa corporal magra
SE9301290D0 (sv) Anvaendning av en somatostatinanalog
NO305581B1 (no) Anvendelse av et benaktivt fosfonat i kombinasjon med et °strogenhormon, og preparat i enhetsdoseform for behandling av osteoporose
HU883863D0 (en) Process for the preparation of producing and/or portionly form of therapeutical agents
BE898749A (fr) Nouveau procede de preparation de formes galeniques utiles notamment en therapeutique, dietetique, cosmetique et diagnostic
DE3650358D1 (de) Diphosphonate enthaltende pharmazeutische Zusammensetzungen zur Behandlung von Arthrosis.
ES2176495T3 (es) Utilizacion de un antagonista de la bradiquinina, destinada a inducir y/o estimular el crecimiento de los cabellos y/o frenar su caida.
ES2061826T3 (es) Un procedimiento de preparacion de derivados n-2,3-butadienil triaminoalcanos.
BE885793A (fr) Sels d'acides 6,7-dihalo-3,4-dihydro-3-oxo-2-quinoxalinecarboxyliques et d'amines steriquement encombrees, leur preparation et leur utilisation therapeutique
KR900007434A (ko) 시스타틴을 유효 성분으로하는 치료제
IT8423896A0 (it) Diacilderivati della glicerilfosforilcolina ad attivita' terapeutica, procedimento per laloro preparazione e relative composizioni farmaceutiche.
IT8026233A0 (it) Derivato della n-acetil-cisteina ad attivita' terapeutica, procedimento per la sua preparazione e relative composizioni farmaceutiche.
FI914939A0 (fi) Preparat foer nagel-, hud- och haorvaord.
HUP9903679A2 (hu) Olanzapin alkalmazása bipoláris zavar kezelésére szolgáló gyógyszerkészítmények előállítására
NO166280C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive n,n'-disubstituerte ureaer.
GB2004183A (en) Compositions containing caffeine and ephedrine or their derivatives
KR900017599A (ko) 종양 치료용 약학 조성물
KR880002521A (ko) 약제 제형
Sulkin et al. Effects of Various Anesthetic Agents on the Blood Pressure of the White Rat.
ATE72397T1 (de) Pharmazeutische zusammensetzungen zur behandlung von hyperproliferativer hautkrankheit.
Beauchene Animal model studies of therapeutic tissue expansion

Legal Events

Date Code Title Description
AHS Application shelved for other reasons than non-payment